Nicholas Campbell

4.0k total citations
26 papers, 474 citations indexed

About

Nicholas Campbell is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Nicholas Campbell has authored 26 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 5 papers in Otorhinolaryngology. Recurrent topics in Nicholas Campbell's work include Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Neuroblastoma Research and Treatments (3 papers). Nicholas Campbell is often cited by papers focused on Head and Neck Cancer Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Neuroblastoma Research and Treatments (3 papers). Nicholas Campbell collaborates with scholars based in United States, Ireland and Australia. Nicholas Campbell's co-authors include Hedy L. Kindler, Ravi Salgia, Everett E. Vokes, Smruti J. Vidwans, Walter M. Stadler, Gregory A. Otterson, Phillip A. Dennis, Jeff Shrager, George R. Simon and Raphael Bueno and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Nicholas Campbell

25 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Campbell United States 11 264 127 108 94 60 26 474
Eun‐Jung Jung South Korea 14 188 0.7× 131 1.0× 180 1.7× 172 1.8× 80 1.3× 23 559
Khoon Leong Chuah Singapore 9 108 0.4× 55 0.4× 118 1.1× 90 1.0× 31 0.5× 30 349
Victor Hugo Fonseca de Jesus Brazil 12 173 0.7× 70 0.6× 247 2.3× 134 1.4× 40 0.7× 57 410
Takachika Ozawa Japan 13 101 0.4× 87 0.7× 118 1.1× 135 1.4× 39 0.7× 28 417
Akiko Fujii Japan 12 215 0.8× 158 1.2× 152 1.4× 86 0.9× 18 0.3× 52 459
Hong Jo Choi South Korea 12 174 0.7× 148 1.2× 276 2.6× 177 1.9× 52 0.9× 25 546
Shinji Katsushima Japan 10 131 0.5× 74 0.6× 87 0.8× 94 1.0× 67 1.1× 21 454
Tad J. Wieczorek United States 11 146 0.6× 72 0.6× 129 1.2× 191 2.0× 67 1.1× 23 480
Motohiko Tokuhisa Japan 11 167 0.6× 144 1.1× 195 1.8× 139 1.5× 53 0.9× 32 484
Seong Woo Hong South Korea 11 126 0.5× 87 0.7× 234 2.2× 85 0.9× 47 0.8× 28 458

Countries citing papers authored by Nicholas Campbell

Since Specialization
Citations

This map shows the geographic impact of Nicholas Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Campbell more than expected).

Fields of papers citing papers by Nicholas Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Campbell. The network helps show where Nicholas Campbell may publish in the future.

Co-authorship network of co-authors of Nicholas Campbell

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Campbell. A scholar is included among the top collaborators of Nicholas Campbell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Campbell. Nicholas Campbell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yan, et al.. (2025). iClick-Mediated Au(I) Functionalization of Polystyrene: Lighting Up Polystyrene with Phosphorescence. ACS Applied Polymer Materials. 7(5). 3134–3146.
2.
Pai, Sara I., Ashok Muniappan, Jong Chul Park, et al.. (2022). A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement.. Journal of Clinical Oncology. 40(16_suppl). 2590–2590. 5 indexed citations
3.
Bowden, Patrick, Andrew See, Nathan Lawrentschuk, et al.. (2021). 68Ga-PSMA-PET screening and transponder-guided salvage radiotherapy to the prostate bed alone for biochemical recurrence following prostatectomy: interim outcomes of a phase II trial. World Journal of Urology. 39(11). 4117–4125. 1 indexed citations
4.
Pai, Sara I., Ramon A. Franco, Ashok Muniappan, et al.. (2021). Patient-reported outcomes (PROs) from a phase II trial of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal and/or pulmonary involvement.. Journal of Clinical Oncology. 39(15_suppl). 6080–6080. 3 indexed citations
5.
Pai, Sara I., Aaron D. Friedman, Ramon A. Franco, et al.. (2019). A phase II study of pembrolizumab for HPV-associated papilloma patients with laryngeal, tracheal, and/or pulmonary involvement.. Journal of Clinical Oncology. 37(15_suppl). 2502–2502. 13 indexed citations
6.
Ajmani, Gaurav S., et al.. (2018). Association of a Proactive Swallowing Rehabilitation Program With Feeding Tube Placement in Patients Treated for Pharyngeal Cancer. JAMA Otolaryngology–Head & Neck Surgery. 144(6). 483–483. 16 indexed citations
7.
Tan, Yi‐Hung Carol, et al.. (2016). The Chicago Thoracic Oncology Database Consortium: A Multisite Database Initiative. Cureus. 8(3). e533–e533. 3 indexed citations
8.
Campbell, Nicholas, Thomas A. Hensing, Mihir K. Bhayani, Arif Y. Shaikh, & Bruce Brockstein. (2016). Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck. Expert Review of Anticancer Therapy. 16(8). 847–858. 6 indexed citations
9.
Campbell, Nicholas, Rangesh Kunnavakkam, Natasha B. Leighl, et al.. (2012). Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium. Lung Cancer. 78(1). 76–80. 45 indexed citations
10.
West, Lisandra, Smruti J. Vidwans, Nicholas Campbell, et al.. (2012). A Novel Classification of Lung Cancer into Molecular Subtypes. PLoS ONE. 7(2). e31906–e31906. 91 indexed citations
11.
Madrid, Andrés Morales La, Nicholas Campbell, Sonali M. Smith, Susan L. Cohn, & Ravi Salgia. (2012). Targeting ALK: a promising strategy for the treatment of non-small cell lung cancer, non-Hodgkin’s lymphoma, and neuroblastoma. Targeted Oncology. 7(3). 199–210. 25 indexed citations
12.
Salgia, Ravi, Thomas A. Hensing, Nicholas Campbell, et al.. (2011). Personalized Treatment of Lung Cancer. Seminars in Oncology. 38(2). 274–283. 34 indexed citations
13.
Campbell, Nicholas & Hedy L. Kindler. (2011). Update on Malignant Pleural Mesothelioma. Seminars in Respiratory and Critical Care Medicine. 32(1). 102–110. 57 indexed citations
14.
Larson, Sarah M., Nicholas Campbell, Dezheng Huo, et al.. (2011). High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk Acute Myeloid Leukemia (AML). Leukemia & lymphoma. 53(3). 445–450. 21 indexed citations
15.
Campbell, Nicholas, Rangesh Kunnavakkam, N. B. Leighl, et al.. (2011). Cediranib (C) in patients (pts) with malignant mesothelioma (MM): A phase II trial of The University of Chicago Phase II Consortium.. Journal of Clinical Oncology. 29(15_suppl). 7027–7027. 2 indexed citations
16.
Campbell, Nicholas, Kristen Wroblewski, Robert G. Maki, et al.. (2011). Final results of a University of Chicago phase II consortium trial of sorafenib (SOR) in patients (pts) with imatinib (IM)- and sunitinib (SU)-resistant (RES) gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 29(4_suppl). 4–4. 9 indexed citations
17.
Campbell, Nicholas. (2010). Neoadjuvant treatment of esophageal cancer. World Journal of Gastroenterology. 16(30). 3793–3793. 49 indexed citations
18.
Larson, Sarah M., Nicholas Campbell, Dezheng Huo, et al.. (2009). High Dose Cytarabine (HiDAC) and Mitoxantrone (MITO) Is An Effective Induction Therapy for High-Risk Acute Myeloid Leukemia (AML).. Blood. 114(22). 1048–1048. 2 indexed citations
19.
Morrow, Bernice E., et al.. (1995). Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.. Heart. 74(2). 205–205. 9 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eun‐Jung Jung Breakdown of academic impact, for papers by Khoon Leong Chuah Breakdown of academic impact, for papers by Victor Hugo Fonseca de Jesus Breakdown of academic impact, for papers by Takachika Ozawa Breakdown of academic impact, for papers by Akiko Fujii Breakdown of academic impact, for papers by Hong Jo Choi Breakdown of academic impact, for papers by Shinji Katsushima Breakdown of academic impact, for papers by Tad J. Wieczorek Breakdown of academic impact, for papers by Motohiko Tokuhisa Breakdown of academic impact, for papers by Seong Woo Hong
Rankless by CCL
2026